Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
For better result, minimum character length is four(4)
China-based biopharmas reported higher Q1 revenues...
WuXi PharmaTech Inc. reported Q1 revenues were 69% higher...
Yesterday, WuXi PharmaTech, the Shanghai-based CRO,...
WuXi PhamaTech released positive Q1 results though...
WuXi PharmaTech has extended its collaboration with...
Japan-based Daiichi Sankyo will buy a majority stake in...
Burrill & Company, together with BIOCOM, hosted the...
Last week, much of the news about China’s...
WuXi PharmaTech and Covance Inc. signed a Memorandum of...
Last week witnessed the formation of an unusually high...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
